0000914190-21-000251.txt : 20210811 0000914190-21-000251.hdr.sgml : 20210811 20210811192312 ACCESSION NUMBER: 0000914190-21-000251 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210809 FILED AS OF DATE: 20210811 DATE AS OF CHANGE: 20210811 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jain Sachin H. CENTRAL INDEX KEY: 0001841806 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52082 FILM NUMBER: 211165109 MAIL ADDRESS: STREET 1: C/O CARDIOVASCULAR SYSTEMS, INC. STREET 2: 1225 OLD HIGHWAY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardiovascular Systems Inc CENTRAL INDEX KEY: 0001180145 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411698056 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1225 OLD HWY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 BUSINESS PHONE: 651-259-1600 MAIL ADDRESS: STREET 1: 1225 OLD HWY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 FORMER COMPANY: FORMER CONFORMED NAME: REPLIDYNE INC DATE OF NAME CHANGE: 20020813 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2021-08-09 0001180145 Cardiovascular Systems Inc CSII 0001841806 Jain Sachin H. C/O CARDIOVASCULAR SYSTEMS, INC. 1225 OLD HIGHWAY 8 NW ST. PAUL MN 55112 1 0 0 0 Common Stock 2021-08-09 4 A 0 1447 0 A 1447 D Restricted Stock Units Common Stock 1333 1333 D Restricted Stock Units 2021-08-09 4 A 0 3814 0 A Common Stock 3814 3814 D Represents restricted stock received at the election of the reporting person, in lieu of cash payment, as a retainer for service as a director of the Company during fiscal year 2022. Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership. Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 954 shares on each of September 30, 2021 and December 31, 2021 and as to 953 shares on each of March 31, 2022 and June 30, 2022. /s/ Andrew Nick as Attorney-in-Fact for Sachin H. Jain pursuant to Power of Attorney filed herewith. 2021-08-11 EX-24 2 attachment_1.htm SACHIN JAIN POWER OF ATTORNEY

POWER OF ATTORNEY



 The undersigned hereby constitutes and appoints Alexander

Rosenstein, Jeffrey Points, Anne Meyer, Christopher J. Melsha, Joseph Schauer,

Andrew Nick or Edward Peilen, or any one of them acting alone, the undersigned's

true and lawful attorney-in-fact and agent with full power of substitution and

resubstitution, for the undersigned and in the undersigned's name, place and

stead, in any and all capacities, to sign any or all Forms 3, 4 or 5

relating to beneficial ownership of securities of Cardiovascular Systems,

Inc. (the "Issuer"), to file the same, with all exhibits thereto and other

documents in connection therewith, with the Securities and Exchange

Commission and to deliver a copy of the same to the Issuer, granting unto

said attorney-in-fact and agent full power and authority to do and perform

each and every act and thing requisite and necessary to be done in and about

the premises, as fully to all intents and purposes as the undersigned might

or could do in person, hereby ratifying and confirming all said attorney-in-

fact and agent, or his substitute or substitutes, may lawfully do or cause

to be done by virtue thereof.  The undersigned acknowledges that the

foregoing attorney-in-fact, in serving in such capacity at the request of

the undersigned, is not assuming any of the undersigned's responsibilities

to comply with Section 16 of the Securities Exchange Act of 1934.



 This Power of Attorney shall remain in effect until such time as the

undersigned is no longer subject to the provisions of Section 16 of the

Securities Exchange Act of 1934 with respect to securities of the Issuer.



 The undersigned hereby indemnifies the attorneys-in-fact for all

losses and costs the attorneys-in-fact may incur in connection with or

arising from the attorneys-in-fact's execution of their authorities granted

hereunder.



 IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney

to be executed as of this 2nd day of August, 2021.



     /s/ Sachin H. Jain